Delivery of cells into the spinal canal for neurological targets.
Injecting cells directly into the cerebrospinal fluid surrounding the brain and spinal cord—bypassing the blood-brain barrier and placing cells near neurological tissue. It's invasive (requiring a lumbar puncture) but targets the right compartment for spinal and neurodegenerative conditions. Risks include infection, headache, and nerve injury, though serious complications are rare with skilled practitioners. Clinics offering intrathecal delivery for neurological conditions are signalling commitment to appropriate targeting, but ask about their infection-prevention protocols and whether they monitor CSF parameters before and after to confirm cells distributed evenly.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment